Booth Andrew
Chief Financial Officer
Booth Andrew has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Booth Andrew is listed as Chief Financial Officer at AbCellera Biologics Inc. Inside the rolling window, Booth Andrew reported 2 open-market purchases totaling $530K in ABCL and no open-market sales. The largest disclosed transaction in the window is a purchase of 37,200 ABCL shares on Aug 14, 2026, worth $384K.
Companies traded
Other insiders at ABCL
Insider Buying
$530K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Booth Andrew made?
Booth Andrew has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Booth Andrew trade?
Booth Andrew has filed SEC Form 4 disclosures for 1 company, including ABCL.
When was Booth Andrew's most recent SEC Form 4 filing?
Booth Andrew's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Booth Andrew's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Booth Andrew is listed as Chief Financial Officer.
What is Booth Andrew's total buy and sell value in the current window?
Inside the rolling retention window, Booth Andrew bought $530K and sold $0 based on SEC Form 4 filings.
What was Booth Andrew's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 37,200 ABCL shares on 2026-08-14, worth $384K, per SEC Form 4 filings.